Skip to main content
. 2024 Mar 4;24:294. doi: 10.1186/s12885-024-12048-5

Table 3.

Univariate and multivariate analyses of prognostic factors for recurrence-free survival of TSCC

Variables Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Age: ≤67 years vs. > 67 years 0.97 (0.40–2.32) 0.936
Sex: female vs. male 0.59 (0.25–1.43) 0.242
Pathological T stage: T1/2 vs. T3/4a 2.14 (0.89–5.17) 0.091
Metastasis of cervical lymph node: Absent vs. Present 3.31 (1.36–8.05) 0.008 3.29 (1.23–8.76) 0.017
TNM stage: I-II vs. III-IV 2.46 (0.98–6.19) 0.056
Tumor size(mm): ≤25 mm vs. > 25 mm 2.07 (0.84–5.06) 0.112
Depth of Invasion(mm): ≤8 mm vs. > 8 mm 2.33 (0.93–5.86) 0.072
Histological differentiation: Mod/Poor vs. Well 0.51 (0.21–1.23) 0.134
Mode of invasion (YK classification): 1–3 vs. 4 C/4D 1.79 (0.73–4.40) 0.201
Visual type of proliferation: Superficial/Exophytic vs. Endophytic 0.93 (0.37–2.34) 0.880
Venous invasion: Negative vs. Positive 1.73 (0.72–4.16) 0.221
Perineural invasion: Negative vs. Positive 2.99 (1.19–7.52) 0.020 2.22 (0.86–5.77) 0.101
Lymph duct invasion: Negative vs. Positive 1.72 (0.63–4.74) 0.293
IgG4 expression: Low vs. High 0.33 (0.13–0.85) 0.022 0.22 (0.07–0.62) 0.005
Foxp3 expression: Low vs. High 0.31 (0.12–0.82) 0.018 0.27 (0.10–0.74) 0.011